EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+52.23%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$4.46B
AUM Growth
+$4.46B
(+49%)
Cap. Flow
+$210M
Cap. Flow
% of AUM
4.7%
Top 10 Holdings %
Top 10 Hldgs %
30.17%
Holding
145
New
24
Increased
36
Reduced
22
Closed
11
Top Buys
| 1 |
Pliant Therapeutics
PLRX
|
$88.4M |
| 2 |
Zentalis Pharmaceuticals
ZNTL
|
$42.5M |
| 3 |
Trane Technologies
TT
|
$40.2M |
| 4 |
Exact Sciences
EXAS
|
$30.3M |
| 5 |
Fiverr
FVRR
|
$29.4M |
Top Sells
| 1 |
Twilio
TWLO
|
$65.6M |
| 2 |
Xylem
XYL
|
$51.6M |
| 3 |
ZGNX
Zogenix, Inc.
ZGNX
|
$44M |
| 4 |
Varonis Systems
VRNS
|
$26.7M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$22.7M |
Sector Composition
| 1 | Healthcare | 46.53% |
| 2 | Technology | 23.12% |
| 3 | Industrials | 9.16% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Communication Services | 3.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Magna International
MGA
$12.7B
| $32.7M | 0.71% |
734,700
+16,700
| +2% | +$744K |
|
52
Palo Alto Networks
PANW
$128B
| $32.6M | 0.71% |
851,022
| – | – |
|
53
Rocket Pharmaceuticals
RCKT
$358M
| $32.4M | 0.71% |
1,550,000
+135,000
| +10% | +$2.83M |
|
54
Novanta
NOVT
$4.05B
| $29.9M | 0.65% |
280,000
| – | – |
|
|
55
Fiverr
FVRR
$864M
| $29.4M | 0.64% |
+398,299
| New | +$29.4M |
|
56
Datadog
DDOG
$46.2B
| $28.6M | 0.62% |
329,000
| – | – |
|
|
STSA
57
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $28.3M | 0.61% |
983,382
| – | – |
|
58
Rollins
ROL
$27.3B
| $27.1M | 0.59% |
958,500
-201,000
| -17% | -$5.68M |
|
|
TPTX
59
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $24.7M | 0.54% |
+383,000
| New | +$24.7M |
|
60
Veracyte
VCYT
$2.41B
| $24.1M | 0.52% |
930,000
| – | – |
|
61
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.46B
| $23.9M | 0.52% |
839,100
-5,500
| -0.7% | -$157K |
|
62
Crinetics Pharmaceuticals
CRNX
$3.26B
| $23.6M | 0.51% |
1,347,000
+400,000
| +42% | +$7.01M |
|
63
uniQure
QURE
$954M
| $22.5M | 0.49% |
500,000
| – | – |
|
64
Okta
OKTA
$15.8B
| $21.6M | 0.47% |
108,000
| – | – |
|
65
Cognex
CGNX
$7.38B
| $21.4M | 0.47% |
+359,000
| New | +$21.4M |
|
|
AY
66
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $21.4M | 0.47% |
736,000
-125,700
| -15% | -$3.66M |
|
|
TRIL
67
DELISTED
Trillium Therapeutics Inc.
TRIL
| $20.6M | 0.45% |
+2,547,000
| New | +$20.6M |
|
68
KalVista Pharmaceuticals
KALV
$713M
| $20.3M | 0.44% |
1,680,000
| – | – |
|
69
MongoDB
MDB
$25.5B
| $19.5M | 0.42% |
86,000
| – | – |
|
70
Regeneron Pharmaceuticals
REGN
$59.8B
| $19.3M | 0.42% |
30,900
| – | – |
|
71
Skyworks Solutions
SWKS
$10.9B
| $18.9M | 0.41% |
148,200
+13,000
| +10% | +$1.66M |
|
72
Dianthus Therapeutics
DNTH
$781M
| $17.7M | 0.39% |
147,478
+35,625
| +32% | +$4.28M |
|
|
SGEN
73
DELISTED
Seagen Inc. Common Stock
SGEN
| $17.4M | 0.38% |
102,500
| – | – |
|
74
XPO
XPO
$14.8B
| $17M | 0.37% |
636,107
| – | – |
|
75
Xenon Pharmaceuticals
XENE
$2.99B
| $16M | 0.35% |
1,274,100
| – | – |
|